• Home
  • News
  • Market Data
  • Participants
  • Émetteurs
  • Investisseurs
  • Education
  • Profil


Notre site utilise des cookies. Cela nous permet d'optimiser votre expérience utilisateur. En poursuivant votre navigation sur ce site, vous acceptez l'utilisation de cookies. Vous trouverez de plus amples informations dans notre déclaration de confidentialité.




30.06.2017 Issuers

SIX Swiss Exchange welcomes a new Stage partner

Baader Helvea is joining Vontobel and Zürcher Kantonalbank as the third research partner in the Stage program from SIX Swiss Exchange.

Since September 2016, SIX Swiss Exchange has been supporting listed companies to enhance their presence in the market and with other important stakeholders through its Stage program. Baader Helvea, Vontobel and Zürcher Kantonalbank offer small and medium-sized companies the possibility of receiving research coverage.

Successful launch of the Stage program

«We are delighted to welcome another renowned research partner in the shape of Baader Helvea,» says Andrea von Bartenwerffer, Head Account Management Issuer Relations at SIX Swiss Exchange. «The program has attracted a lot of interest from capital market participants since its launch. Eight companies are now reaping the benefits of the Stage program.»

Stefan Weber, CEO Newron Pharmaceuticals S.p.A, which participates in the program: «We welcome this initiative from SIX Swiss Exchange, which, in collaboration with its partners, is determined to counteract the decreasing research coverage of SMEs in recent years.»

Raising awareness of listed companies

The Stage program supports small and medium-sized enterprises in increasing their visibility and achieving an appropriate valuation. It offers listed companies the option of research coverage. This research coverage complements the basic package, under which issuers enjoy a regularly updated fact sheet compiled by Morningstar as well as training organized by SIX Swiss Exchange and specific, target-group-relevant information and events.

Further information on the Stage program for issuers can also be found in our brochure[pdf].


Show all news